Home Tepha Inc

Tepha Inc

    Tepha Inc. Announces the Presentation of Pre-Clinical and Clinical Data on the Use of P4HB™ Regenerative Scaffolds In Urogynecology

    Fully resorbable scaffolds manufactured from Tepha's P4HB polymer were first introduced in 2012 and have now been safely used in more than 200,000 surgical procedures around the world in both complex abdominal wall reconstruction as well as plastic and reconstructive surgery applications.

    Tepha Inc. Announces Initiation of Clinical Evaluation of P4HB™ Regenerative Scaffold for Stress Urinary Incontinence

    2/27/19: The study was initiated in Cape Town, South Africa in partnership with the Pelvic Floor Foundation of South Africa ("PFFSA") and the University of Cape Town.

    Galatea Surgical, Subsidiary of Tepha Inc., Announces Publication of GalaFLEX™ Post-Market Study Results

    5/1/18: The results of this study also were discussed by the investigators with leading plastic surgeons at the American Society of Aesthetic Plastic Surgery ("ASAPS") Annual Meeting.

    Tepha Inc. Announces Regenerative Medicine Recent Developments and R & D Initiatives

    11/9/17: Tepha Inc., a developer and marketer of implantable medical devices based on its proprietary P4HB™ resorbable polymer technology, announced today recent developments and R & D initiatives in the field of regenerative medicine scaffolds for the repair or replacement of compromised human tissue.

    Tepha Inc. Subsidiary, Galatea Surgical, Announces the Launch of GalaFORM™ 3D Surgical Scaffold

    Andy Joiner, President and CEO of Tepha commented, "One of the cornerstones of Galatea is our commitment to surgeon and patient education. We are...

    RECENT COMMENTS